Quarterly report pursuant to Section 13 or 15(d)

Debt - Narrative (Details)

v3.24.1.1.u2
Debt - Narrative (Details)
$ in Thousands
 3 Months Ended
Dec. 06, 2023
USD ($)
Aug. 14, 2023
USD ($)
day
Mar. 15, 2023
Jul. 06, 2022
USD ($)
Mar. 31, 2024
USD ($)
shares
Mar. 31, 2023
USD ($)
Debt Instrument [Line Items]            
Common stock issued upon conversion of 2022 Promissory Note         $ 4,505 $ 0
Interest expense         $ 108 $ 537
2022 Promissory Note            
Debt Instrument [Line Items]            
Common stock issued upon conversion of 2022 Promissory Note (in shares) | shares         336,550  
Common stock issued upon conversion of 2022 Promissory Note         $ 4,505  
Debt instrument waived amount         $ 535  
2022 Promissory Note | Notes Payable            
Debt Instrument [Line Items]            
Principal amount of note       $ 12,809    
Original issue discount       492    
Other issuance costs       522    
Proceeds from issuance of debt       11,795    
Monthly amortization payments       $ 1,566    
Debt premium (as a percent)       10.00%    
Payment deferral period       1 month    
Number of times a payment may be deferred       12    
Debt amount increase (as a percent)       0.0185    
Compensation agreed to be paid (as a percent)     5.00%      
Conversion price (as a percent)   90.00%        
Threshold trading days | day   5        
Extension fee   $ 708        
Interest rate (as a percent)   8.00%        
Noteholder fee as percentage of outstanding balance 7.50%          
Noteholder fee $ 347          
2022 Promissory Note | Notes Payable | Minimum            
Debt Instrument [Line Items]            
Monthly amortization payments   $ 800